Skip to main content

Table 6 Risk factors for clot retention in AP/AC continuation group

From: Risks and complications of transurethral resection of bladder tumors in patients receiving antiplatelet and/or anticoagulant therapy: a retrospective cohort study

  

Clot retention (+)

n = 4, n (%)

Clot retention (−)

n = 15, n (%)

p value

Median age (range)

77

(63–89)

77

(57–85)

0.76

Median tumor size, cm (range)

2

(1.5–3)

0.8

(0.5–3)

0.07

Tumor number

Single

1

(25)

10

(67)

0.26

 

Multiple

3

(75)

5

(33)

 

T classification at TURBT

pTa

1

(25)

7

(47)

0.43

pT1

3

(75)

6

(40)

 

Min. pT2

0

(0)

2

(13)

 

AP/AC drugs

Single AP

4

(100)

7

(47)

0.16

Single AC

0

(0)

3

(20)

 

Combination

0

(0)

5

(33)

 
  1. AP antiplatelet agents, AC anticoagulant agents, Min minimum